Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Nausherwan K Burki"'
Autor:
Nausherwan K. Burki
Publikováno v:
Respiratory care. 65(1)
Respiratory failure is manifested by a derangement of arterial blood gases, and the relationship of arterial blood gases to the matching of ventilation (V) to perfusion (Q) in the lungs is critical to understanding the mechanisms of respiratory failu
Autor:
Nausherwan K Burki
Publikováno v:
International Journal of Neurorehabilitation.
Respiratory muscle dysfunction results in significant symptoms and morbidity. The diaphragm is the primary muscle of inspiration and understanding the function and innervation of the respiratory muscles is essential to identify respiratory muscle dys
Autor:
Christian Putensen, Stefan Blaas, Lars Hagmeyer, Raj Kumar Mani, Werner Schmidt, Christina Priegnitz, Nausherwan K. Burki, Sven Stieglitz, Michael Quintel, Felix J.F. Herth, Winfried Randerath, Heinrich D. Becker, Frank Bonin, Helmut Teschler, Nils Theuerkauf, Onnen Moerer, Michael Pfeifer
Publikováno v:
Chest. 143(3):678-686
Background Hypercapnic respiratory failure in patients with COPD frequently requires mechanical ventilatory support. Extracorporeal CO 2 removal (ECCO 2 R) techniques have not been systematically evaluated in these patients. Methods This is a pilot s
Publikováno v:
5.1 Airway Pharmacology and Treatment.
Introduction: The mechanism of bronchodilator nonresponsiveness to corticosteroids in COPD is unclear; the levels of histone deacytylase (HDAC) and oxidative stress have been implicated (New Engl J Med, 2005;352:1967). Phosphodiesterase (PDE4) inhibi
Publikováno v:
Connecticut medicine. 80(2)
Lipoid pneumonia is a rare, underdiagnosed disorder, and its combined presentation with sarcoidosis is even more unusual.This paper presents a case in which both lipoid pneumonia and sarcoidosis were present, and includes the relevant literature revi
Autor:
Mahmood Alam, Nausherwan K. Burki
Publikováno v:
Southern Medical Journal. 100:49-53
Chronic eosinophilic pneumonia (CEP) is a disease of unknown cause. The hallmark of CEP is eosinophil accumulation in the lungs. While the triggering factor is unknown, eosinophil accumulation in the lungs is now believed to be secondary to the actio
Publikováno v:
Journal of Applied Physiology. 95:1315-1324
Compelling clinical evidence implicates the potential role of adenosine in development of airway hyperresponsiveness and suggests involvement of pulmonary sensory receptors. This study was carried out to determine the effect of a low dose of adenosin
Autor:
Nausherwan K. Burki
Publikováno v:
Southern medical journal. 107(5)
Publikováno v:
Journal of Asthma. 38:59-64
Beta2-agonist drugs at inhaled supratherapeutic doses or when given orally or parenterally alter peripheral lymphocyte beta2-adrenoceptor density (betaAR) and have demonstrable metabolic effects. However, it is not known whether these changes occur a
Autor:
Nausherwan K, Burki, Raj Kumar, Mani, Felix J F, Herth, Werner, Schmidt, Helmut, Teschler, Frank, Bonin, Heinrich, Becker, Winfried J, Randerath, Sven, Stieglitz, Lars, Hagmeyer, Christina, Priegnitz, Michael, Pfeifer, Stefan H, Blaas, Christian, Putensen, Nils, Theuerkauf, Michael, Quintel, Onnen, Moerer
Publikováno v:
Chest. 143(3)
Hypercapnic respiratory failure in patients with COPD frequently requires mechanical ventilatory support. Extracorporeal CO2 removal (ECCO2R) techniques have not been systematically evaluated in these patients.This is a pilot study of a novel ECCO2R